deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT00262054

Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)

Prospective, Randomized, Double-Blind, Active-Controlled, Multicenter Trial of Bivalirudin and Un-fractionated Heparin in Patients Undergoing Percutaneous Coronary Interventions. ISAR-REACT-3

Sponsor: Deutsches Herzzentrum Muenchen

Conditions Angina Pectoris Coronary Disease
Interventions Bivalirudin Un-fractionated heparin
Updated 5 times since 2017 Last updated: Mar 12, 2010 Started: Nov 30, 2005 Primary completion: Feb 29, 2008 Completion: May 31, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Angina Pectoris and Coronary Disease, this trial is completed. The trial is conducted by Deutsches Herzzentrum Muenchen and has accumulated 5 data snapshots since 2005. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Deutsches Herzzentrum Muenchen
Data source: Deutsches Herzzentrum Muenchen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations